Browsing Centre for Experimental Medicine and Rheumatology (EMR) by Author "Price, E"
Now showing items 1-2 of 2
-
Corrigendum: Eligibility for clinical trials in primary Sjögren's syndrome: Lessons from the UK Primary Sjögren's Syndrome Registry [Rheumatology, 55, (2016) (544-552)] doi:10.1093/rheumatology/kev373
Oni, C; Mitchell, S; James, K; Ng, W-F; Griffiths, B; Hindmarsh, V; Price, E; Pease, CT; Emery, P; Lanyon, P (2017-08-18)This is a correction to: Rheumatology, Volume 55, Issue 3, March 2016, Pages 544–552, https://doi.org/10.1093/rheumatology/kev373 -
Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjogren's syndrome: a randomized, phase 2, double-blind, placebo-controlled study
Price, E; Bombardieri, M; Kivitz, A; Matzkies, F; Gurtovaya, O; Pechonkina, A; Jiang, W; Downie, B; Mathur, A; Mozaffarian, A (2022)